Antiretroviral-Drug Resistance among Patients Recently Infected with HIVSusan J. Little, Douglas D. Richman, Marty Markowitz et al.|New England Journal of Medicine|2002Cited by 1.1k
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trialsChloe Orkin, Christine Katlama, Jean‐Michel Molina et al.|The Lancet HIV|2023Cited by 31